光动力疗法
化学
基因沉默
光敏剂
遗传增强
癌症研究
单线态氧
体内
细胞
脱氧核酶
光化学
DNA
基因
医学
生物化学
氧气
生物
有机化学
生物技术
作者
Xudong Wang,Jun Dai,Xiangyu Wang,Qinyu Hu,Kaixun Huang,Zujin Zhao,Xiaoding Lou,Fan Xia
出处
期刊:Talanta
[Elsevier BV]
日期:2019-09-01
卷期号:202: 591-599
被引量:45
标识
DOI:10.1016/j.talanta.2019.05.003
摘要
Photodynamic therapy (PDT) was considered as an effective treatment. Whereas only PDT is not enough to achieve effective therapy on account of irradiation intensity decreases as depth increases as well as tumor hypoxia. Combination with gene therapy and photodynamic therapy have emerged as an effective strategy to improve therapeutic effectiveness. In the present study, a GSH responsive MnO2 was employed to delivery TB and DNAzyme for cancer imaging and PDT-gene combination treatment. TB, a photosensiters with aggregation-induced emission characteristic, was employed for photodynamic therapy, while DNAzyme, acting as catalysts for the degradation of EGR-1 mRNA, was exploited for gene silencing. All of the results of tumor treatment in vitro have implied that MnO2-DNAzyme-TB nanocomposite (MDT) can internalize into cells. Subsequently, MDT could decrease the expression of EGR-1 by gene silencing that enabling inhibition of cell growth. In addition, the singlet oxygen which was generated by the aggregated TB were able to further suppress cell growth. Combination therapy of photodynamic as well as gene therapy greatly enhanced antitumor efficiencies. Furthermore, in vivo tumor treatment experiments demonstrated that MDT under illumination can effectively inhibit the tumor growth of MCF-7 tumor-bearing mice by photodynamic and gene silencing combination therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI